「这是风险-获益分析」:澳大利亚血液系统恶性肿瘤成年患者对治疗后疫苗接种障碍与促进因素的定性视角
本研究在澳大利亚一家专科癌症医院对20名血液癌症患者进行半结构化访谈的定性探索研究,探讨治疗后疫苗接种的障碍与促进因素。障碍包括护理协调差、出行、时间与费用、对副作用和伤害的担忧、干预与预约疲劳及对疫苗研发过程的顾虑;促进因素包括咨询式对话、多格式信息、自动预约与提醒、混合与共享照护模式、与可信赖卫生专业人员联系、对公共卫生建议和疫苗研发过程的信心及将接种视为康复核心。结论提示可通过针对性服务创新和教育信息干预改善该人群接种。
要点
- 部分患者在治疗中心接种时体验到协调照护使接种便捷,其他参与者则因缺乏协调照护和连续性而受阻。
- 缺乏疾病特异性信息加上常见疫苗误解导致对疫苗接种的担忧。
- 障碍与促进因素涵盖护理协调、信息形式、预约提醒、照护模式及对公共卫生建议的信心等方面。
核心结论
- 所识别的接种障碍与促进因素提示可改善该人群的疫苗接种服务。
- 部分患者在治疗中心接种时报告协调照护使接种便捷,其他参与者则因缺乏协调照护和连续性而受阻。
- 缺乏疾病特异性信息加上常见疫苗误解导致对疫苗接种的担忧。
- 这些发现为通过针对性服务创新及教育和信息干预解决接种障碍提供了机会。
研究设计与样本
- 在澳大利亚一家专科癌症医院开展的定性探索性研究。
- 通过电话或视频会议对患者进行半结构化访谈,探讨抗癌治疗后疫苗接种的经历与观点及接种的障碍与促进因素。
- 访谈前收集人口学和临床特征并进行描述性分析。
- 定性数据采用模板分析进行归纳分析,然后映射到COM-B行为改变模型并识别障碍与促进因素。
- 二十名血液癌症患者参与。
主要发现
- 参与者描述的障碍包括护理协调差、出行、时间与费用、对潜在副作用和伤害的担忧、干预与预约疲劳及对疫苗研发过程的顾虑。
- 促进因素包括咨询式对话、多格式可获取的信息、自动预约和提醒、混合与共享照护模式、与可信赖卫生专业人员联系、对公共卫生建议和疫苗研发过程的信心及将接种视为康复核心。
- 部分患者在治疗中心接种时报告协调照护使接种便捷,其他参与者则因缺乏协调照护和连续性而受阻。
- 缺乏疾病特异性信息加上常见疫苗误解导致对疫苗接种的担忧。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People affected by haematological malignancies are at high risk of morbidity and mortality caused by vaccine-preventable infections. However, vaccination commencement and completion following anti-cancer treatment is sub-optimal for this population. Innovation relating to vaccination delivery and schedules, informed by the needs and preferences of the target population, may improve uptake of vaccinations. This study explored barriers and enablers to vaccinations, novel vaccines and vaccination schedules, from the perspectives of this cohort. METHODS: A qualitative exploratory study at an Australian specialist cancer hospital. Semi-structured interviews were conducted with patients via telephone or videoconferencing, exploring experiences of, and views regarding, vaccination after anti-cancer treatment, and barriers and enablers to vaccination. Demographic and clinical characteristics were collected prior to interviews and analysed descriptively. Qualitative data were analysed inductively using template analysis, then mapped to the COM-B model of behaviour change, and barriers and enablers identified. RESULTS: Twenty blood cancer patients participated. Participants described barriers including poor care coordination, travel, time, and financial costs, concerns regarding potential side effects and injury, intervention and appointment fatigue, and concerns regarding vaccine development processes. Enablers included: consultative conversations, information available in various formats, automated appointments and reminders, hybrid and shared models of care, being linked-in with trusted health professionals, confidence in public health advice and vaccine development processes, and seeing vaccinations as central to their recovery. CONCLUSION: Barriers and enablers to vaccination identified suggest ways in which vaccination services for this population can be improved. While patients receiving vaccinations at their treating centre reported coordinated care that made access straightforward, other participants described being hampered by lack of coordinated care and continuity. A lack of condition-specific information coupled with common vaccine misconceptions resulted in concerns regarding vaccinations. These findings offer opportunities to address barriers to vaccination uptake through targeted service innovation and education and information interventions.
引用
- Chung H, Krishnasamy M, Joyce T, et al. "It's a risk-benefit analysis": Qualitative perspectives on barriers and enablers to post-treatment vaccination from adults affected by a haematological malignancy in Australia. Vaccine. 2025. PMID: 39893769. doi:10.1016/j.vaccine.2025.126826
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。